Dear BTV shareholders,
On 28 April 2023, the AGM will be held to decide:
1.Change the Company's name from "Baltic Technology Ventures" to "Emerging Nordic Ventures" and related amendments to the Articles of the Association.
2. Conversion of 1,480,780 (one million, four hundred and eighty thousand, seven hundred and eighty) bearer shares into registered shares and related amendments to the Articles of the Association of the joint stock company "Baltic Technology Ventures";
3. Approval of the Company's Articles of the Association in the new version;
4. Approval of the Company's annual report for 2022;
5. Decision on the results of the Company's economic activity in 2022.
The record date for shareholders' participation in the shareholders' meeting is April 20, 2023 until 17.00. Only persons who are shareholders on the record date are entitled to participate in the Company's ordinary shareholders' meeting on April 28, 2023 with the number of shares they own, as well as to vote in writing before the shareholders' meeting by filling in the voting form available.
Please feel free to review the attached documents, the proposed changes, the voting forms and related documents attached below. Should you have any questions please feel free to contact us.
After taking over the registration of 1,480,780 (one million, four hundred and eighty thousand, seven hundred and eighty) registered shares of the joint-stock company "Baltic Technology Ventures" in paper form from Nasdaq CSD SE, and the shareholders' decision coming into force, the board has the right to register registered shares, and their shareholders register. SIA "Mazars Audits", reg. No. 40103512765/ https://www.mazars.lv, the official representative of the international audit firm Mazars in Latvia, is the authorized representative in settlement of the issue of conversion of shares of the Joint Stock Company "Baltic Technology Ventures". If shareholders have questions, please address them by sending requests to e-mail: legal@mazars.lv.
Regards,
BTV Member of the Board
Gene Zolotarev